Bernstein downgraded PEP to Sell from Hold on Wednesday. The firm also cut its target price to $128. PepsiCo carries a $193 billion market cap. Short interest is light at 2.2% of free float. The downgrade stands out as one of only six Sell ratings among 24 analysts covering the stock.
Barclays made the biggest target move of the day on REGN. Analyst Eliana Merle raised her target on Regeneron to $1,075 from $917, a $158 increase. The Buy rating was reiterated.
JP Morgan raised its target on MRNA to $102 from $77. The Sell rating was kept, but the $25 lift signals an improved view on the stock's near-term floor. Moderna's short interest sits at 8.6% of free float. That is the highest of the three biopharma names reviewed today.
Bernstein's Sunaina Ocalan also updated two power names. She trimmed her target on CEG by $3 to $293 while keeping Buy. She raised her target on VST by $1 to $182. Morgan Stanley lifted targets on three insurers: PGR went to $235 from $210, HIG to $145 from $135, and WRB to $80 from $70.